• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗对改善资源匮乏地区宫颈癌手术干预效果的影响:初步报告

Impact of neoadjuvant chemotherapy in improving operative intervention in the management of cervical cancer in low resource setting: a preliminary report.

作者信息

Nwankwo Theophilus Ogochukwu, Umeh Uchenna Anthony, Aniebue Uzochukwu Uzoma, Onu Justus Uchenna, Umeh Chioma Roseline

机构信息

Department of Obstetrics and Gynecology, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria.

Department of Mental Health, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

出版信息

Pan Afr Med J. 2020 Jul 23;36:210. doi: 10.11604/pamj.2020.36.210.24141. eCollection 2020.

DOI:10.11604/pamj.2020.36.210.24141
PMID:32963676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7490144/
Abstract

There is paucity of data on interventions to improve cancer outcome in the low-resource setting. This study aims to determine the effect of Neoadjuvant Chemotherapy (NACT) in improving operative outcomes of cervical cancer. This was a longitudinal intervention study of patients diagnosed with FIGO stage IIB - IIIA cervical cancer that had NACT. Patients were re-evaluated after treatment with 4 cycles of chemotherapy for operability. McNemar test was used to determine changes in operability of the tumour. There was a significant difference in the number of patients that converted from inoperable to operable tumor post-chemotherapy. This study shows some promise for NACT for FIGO stage IIB - IIIA cancer of the cervix, especially in low-resource settings, where radiotherapy is scarce.

摘要

在资源匮乏地区,关于改善癌症治疗结果的干预措施的数据很少。本研究旨在确定新辅助化疗(NACT)对改善宫颈癌手术结果的效果。这是一项对被诊断为FIGO IIB - IIIA期宫颈癌且接受了NACT的患者进行的纵向干预研究。患者在接受4个周期化疗后重新评估手术可行性。采用McNemar检验来确定肿瘤手术可行性的变化。化疗后肿瘤从不可切除转变为可切除的患者数量有显著差异。本研究表明,NACT对FIGO IIB - IIIA期宫颈癌有一定前景,尤其是在放疗资源稀缺的低资源地区。

相似文献

1
Impact of neoadjuvant chemotherapy in improving operative intervention in the management of cervical cancer in low resource setting: a preliminary report.新辅助化疗对改善资源匮乏地区宫颈癌手术干预效果的影响:初步报告
Pan Afr Med J. 2020 Jul 23;36:210. doi: 10.11604/pamj.2020.36.210.24141. eCollection 2020.
2
Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.新辅助化疗联合根治性手术治疗 Ib2-IIb 期宫颈癌患者术后治疗的作用如何?一项意大利多中心回顾性研究。
Gynecol Oncol. 2014 Mar;132(3):611-7. doi: 10.1016/j.ygyno.2013.12.010. Epub 2013 Dec 14.
3
Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.新辅助铂类化疗后行根治性子宫切除术治疗Ib2-IIb期子宫颈腺癌——一项意大利多中心回顾性研究
Anticancer Res. 2018 Jun;38(6):3627-3634. doi: 10.21873/anticanres.12637.
4
Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.新辅助化疗后手术加辅助化疗可改善 IB2-IIB 期宫颈癌患者的临床结局,此类患者先接受新辅助化疗,然后再行根治性手术。
Sci Rep. 2018 Apr 24;8(1):6443. doi: 10.1038/s41598-018-24413-z.
5
Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.新辅助化疗后行根治性手术治疗FIGO IB2/IIA2期宫颈癌的疗效:一项多中心回顾性临床研究。
Medicine (Baltimore). 2019 May;98(21):e15604. doi: 10.1097/MD.0000000000015604.
6
The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial.新辅助化疗在宫颈鳞状细胞癌(Ib-IIIb期)中的作用:一项长期随机试验。
Eur J Gynaecol Oncol. 2003;24(1):51-9.
7
Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.新辅助化疗后对局部晚期宫颈癌女性进行机器人根治性子宫切除术的可行性
Eur J Surg Oncol. 2016 Sep;42(9):1372-7. doi: 10.1016/j.ejso.2016.04.060. Epub 2016 May 18.
8
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.新辅助化疗后行根治性手术治疗 IB2 期至 IIB 期宫颈癌的临床评价。
Int J Gynaecol Obstet. 2012 Apr;117(1):23-6. doi: 10.1016/j.ijgo.2011.11.017. Epub 2012 Jan 21.
9
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).新辅助化疗联合根治性子宫切除术治疗 Ib2-IIb 期宫颈癌患者的手术标本病理反应是独立的预后变量:一项意大利多中心回顾性研究(CTF 研究)。
Gynecol Oncol. 2013 Dec;131(3):640-4. doi: 10.1016/j.ygyno.2013.09.029. Epub 2013 Oct 3.
10
Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.FIGO 分期 Ib2-IIb 期宫颈癌患者接受顺铂为基础的新辅助化疗后行根治性子宫切除术的临床结局预测的临床病理变量。
Anticancer Res. 2010 Jan;30(1):201-8.

引用本文的文献

1
Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study.局部晚期宫颈癌:新辅助化疗联合根治性手术在低收入环境中替代放化疗的一种方法:一项描述性研究。
PLoS One. 2024 Oct 30;19(10):e0310457. doi: 10.1371/journal.pone.0310457. eCollection 2024.
2
Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.基于组织学类型的 2018 年 FIGO 分期 IIIC 期宫颈癌的初始治疗:一项 14 年多中心研究。
Cancer Med. 2023 Oct;12(19):19617-19632. doi: 10.1002/cam4.6586. Epub 2023 Sep 28.
3
Setting priorities for ageing research in Africa: A systematic mapping review of 512 studies from sub-Saharan Africa.设定非洲老龄化研究重点:对撒哈拉以南非洲 512 项研究的系统综述
J Glob Health. 2021 Jun 26;11:15002. doi: 10.7189/jogh.11.15002. eCollection 2021.

本文引用的文献

1
Neoadjuvant chemotherapy in woman with early or locally advanced cervical cancer.早期或局部晚期宫颈癌女性患者的新辅助化疗
Rep Pract Oncol Radiother. 2018 Nov-Dec;23(6):528-532. doi: 10.1016/j.rpor.2018.09.005. Epub 2018 Oct 13.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Integrating Chemotherapy in the Management of Cervical Cancer: A Critical Appraisal.宫颈癌管理中化疗的整合:批判性评估
Oncology. 2016;91 Suppl 1:8-17. doi: 10.1159/000447576. Epub 2016 Jul 28.
4
Neoadjuvant chemotherapy in cervical cancer: an update.宫颈癌新辅助化疗:最新进展
Expert Rev Anticancer Ther. 2015;15(10):1171-81. doi: 10.1586/14737140.2015.1079777. Epub 2015 Sep 7.
5
The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review.新辅助化疗在局部晚期宫颈癌治疗中的作用:一项系统评价
Oncol Rev. 2014 Sep 23;8(2):250. doi: 10.4081/oncol.2014.250.
6
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.剂量密集新辅助化疗联合根治性手术治疗局部晚期宫颈癌:一项II期研究
Oncology. 2015;89(2):103-10. doi: 10.1159/000381461. Epub 2015 Apr 29.
7
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).新辅助化疗联合根治性子宫切除术治疗 Ib2-IIb 期宫颈癌患者的手术标本病理反应是独立的预后变量:一项意大利多中心回顾性研究(CTF 研究)。
Gynecol Oncol. 2013 Dec;131(3):640-4. doi: 10.1016/j.ygyno.2013.09.029. Epub 2013 Oct 3.